Dopamine and Serotonin Play a Role in Human Perception and Decision-Making

Summary: Researchers recorded alterations in levels of both dopamine and serotonin in the brain when people perform perception and decision making based tasks.

Source: Wake Forest Baptist Medical Center

Scientists at Wake Forest School of Medicine have recorded real time changes in dopamine and serotonin levels in the human brain that are involved with perception and decision-making. These same neurochemicals also are critical to movement disorders and psychiatric conditions, including substance abuse and depression.

Their findings are published in the Oct. 12 edition of the journal Neuron.

“This study provides us a unique window into the human brain that has been inaccessible until now,” said principal investigator Kenneth T. Kishida, Ph.D., assistant professor of physiology and pharmacology and neurosurgery at Wake Forest School of Medicine, part of Wake Forest Baptist Health. “Almost everything we have known mechanistically about these neurochemicals was from work done in preclinical animal models, not from direct evidence from humans.”

Having a clearer understanding of how these brain chemicals actually work in people may lead to improved medications or treatments for disorders like Parkinson’s disease, substance use disorder or depression, Kishida said.

In this observational study, the neurotransmitters dopamine and serotonin were tracked in five patients using fast scan cyclic voltammetry, an electrochemical technique used to measure dopamine and serotonin, adapted for use in patients. Dopamine and serotonin are chemical messengers used by the nervous system to regulate countless functions and processes in the body.

Study participants – two with Parkinson’s and three with essential tremor – were patients at Wake Forest Baptist who were scheduled to receive a deep brain stimulating implant to treat their condition. Working closely with neurosurgeons, Stephen B. Tatter, M.D., and Adrian W. Laxton, M.D., Kishida’s team was able to piggyback on the standard surgical mapping process to insert a carbon fiber microelectrode deep into the brain to detect and record serotonin and dopamine released from neurons.

The patients with essential tremor were important to the study because, unlike Parkinson’s disease which is caused by loss of dopamine-producing neurons, essential tremor is not believed to be caused by changes in dopamine or serotonin function.

While the patients were awake in the operating room, they performed decision-making tasks similar to playing a simple computer game. As they performed the tasks, measurements of dopamine and serotonin were taken in the striatum, the part of the brain that controls cognition, reward and coordinated movements.

Kishida described the game as a series of dots on a computer screen that moved through a “cross-hair” reference point positioned in the center of the screen. Patients had to decide which way the dots were moving. Sometimes the dots would move in the same direction and at other times the dots would move more chaotically making the decision harder.

The dots then disappeared and the patient had to choose which way the dots had moved – clockwise or counter clockwise – relative to a fixed point. This experimental design, created by Kishida’s collaborators and co-authors Dan Bang and Stephen M. Fleming, at University College London, allowed the team to tease apart different aspects of how the human brain decides what it has perceived.

This sequence was repeated 200 to 300 times per patient, varying how the dots moved and thus how difficult it was for the patient to decide what they saw. Occasionally, the patients had to indicate how confident they were in their choices.

The test was designed to track the patient’s ability to perceive the dots’ movement and the patient’s confidence in correctly identifying the direction of that movement as a way to determine how dopamine and serotonin actually behaved. The trials were randomized so that predictability from one test trial to the next would be minimized, Kishida said.

The findings showed that the more uncertain the patient was about the direction of the dots, the higher the serotonin levels became. When their certainty increased, serotonin levels decreased.

The study also revealed that, prior to the act of choosing, dopamine rose in anticipation of the choice and serotonin levels fell, and when both reached a certain level, the person made their choice. It’s as if dopamine acted like a gas pedal and serotonin acted like a brake and only when both systems were committed was the act of choice (a button press) allowed, Kishida said.

This shows an orange question mark
The findings showed that the more uncertain the patient was about the direction of the dots, the higher the serotonin levels became. When their certainty increased, serotonin levels decreased. Image is in the public domain.

“This study sheds light on the role these neurochemicals play in learning, brain plasticity and how we perceive the environment,” Kishida said. “We now have more detailed insight into how our brains build what we perceive, use those perceptions to make decisions, and interpret the consequences of the choices we make. Dopamine and serotonin appear to be critical in all of these processes.

“Importantly, studies like this will help us and other scientists develop a better understanding of how drugs or medications like serotonin reuptake inhibitors affect cognition, decision-making, and impact psychiatric conditions like depression.”

The technology used in the study was developed by Kishida during his post-doctoral work at Virginia Tech in collaboration with co-author Read Montague, Ph.D.

Funding: Funding for the study was provided by the National Institutes of Health, National Institute of Neurologic Disorders and Stroke, National Institute of Mental Health, National Institute of Drug Abuse, the Wellcome Trust, and Wake Forest School of Medicine.

About this neuroscience research news

Source: Wake Forest Baptist Medical Center
Contact: Marguerite Beck – Wake Forest Baptist Medical Center
Image: The image is in the public domain.

Original Research: Open access.
Sub-second Dopamine and Serotonin Signaling in Human Striatum during Perceptual Decision-Making” by Dan Bang, Kenneth T. Kishida, Terry Lohrenz, Jason P. White, Adrian W. Laxton, Stephen B. Tatter, Stephen M. Fleming, P. Read Montague. Neuron.


Abstract

Sub-second Dopamine and Serotonin Signaling in Human Striatum during Perceptual Decision-Making

Highlights

  • Dopamine and serotonin are measured in human striatum during awake decision-making
  • Serotonin tracks sensory uncertainty in caudate nucleus
  • Dopamine and serotonin track sensory statistics in caudate nucleus
  • Dopamine and serotonin track decision times in putamen

Summary

Recent animal research indicates that dopamine and serotonin, neuromodulators traditionally linked to appetitive and aversive processes, are also involved in sensory inference and decisions based on such inference. We tested this hypothesis in humans by monitoring sub-second striatal dopamine and serotonin signaling during a visual motion discrimination task that separates sensory uncertainty from decision difficulty in a factorial design. Caudate nucleus recordings (n = 4) revealed multi-scale encoding: in three participants, serotonin tracked sensory uncertainty, and, in one participant, both dopamine and serotonin tracked deviations from expected trial transitions within our factorial design. Putamen recordings (n = 1) supported a cognition-action separation between caudate nucleus and putamena striatal sub-division unique to primates—with both dopamine and serotonin tracking decision times. These first-of-their-kind observations in the human brain reveal a role for sub-second dopamine and serotonin signaling in non-reward-based aspects of cognition and action.

Join our Newsletter
I agree to have my personal information transferred to AWeber for Neuroscience Newsletter ( more information )
Sign up to receive our recent neuroscience headlines and summaries sent to your email once a day, totally free.
We hate spam and only use your email to contact you about newsletters. You can cancel your subscription any time.
  1. Super article from a layman’s perspective. Was very easy to understand. We have heard words like dopamine and serotonin in casual discussions but didn’t know how these are so critical in our decision making at every moment of the day

  2. There was news of a semi-successful head transplant of/on a pig last year.I was given to understand that SomeThing Similar was to occur with a human.My initial thought was shome mishtake shorely but ……… Did? Where? Where should I access information to be readily absorbed by this man on the street? This lay man on this street I means ………… ??.

  3. Hellos! There’s a certain SomeThing which continues to intrigue and perplex in an unequal measure : If we developed the unlikely abilities which enabled us to literally learn to forget how many amongst us wouldthrow their hands into the airs to participate in a kind of procedure involving a scalpel a vapour or a vibration or SomeThing Similar that would Erase our worse memories?
    If we have determined precise areas which contain persistant and persisting memories and the flooding of these aeas produces enhanced theories that the dopomines and serotonins bring out how have we established connections with our reward areas?And this ‘reuptake’ aspect is something that s t r e t c h e s my understanding leaving my comprehension strung-out on the subs bench.Is there SomeOne out and about yet in and around an answer or two that may satisfy/stimulate this inquisitivity that refused to drop me out?
    Is there such a matter of an assortment of answers made available to The Laymans Questions? And also ………….

Your email address will not be published. Required fields are marked *